Abstract

An asymmetric synthesis of 3-aryl-3,4-dihydroisocoumarins using the reaction of laterally lithiated 4,4-dimethyl-2-(o-tolyl)oxazoline with aromatic aldehydes, in the presence of an external chiral ligand, gave products with enantiomeric excess (ee) in the range of 60-70%.

Highlights

  • The 3-aryl-3,4-dihydroisocoumarins 1 constitute a class of natural products, which exhibit a wide range of pharmacological activities such as antifungal, antiulcer, antileukemic, antiallergic, differentiation-inducing and antimalarial activities.[1]

  • In the majority of these approaches the chiral moiety is present in the substrate and needs removal after reaction.2a-g Recently, Kurosaki et al reported the stereoselective addition of laterally lithiated (S)-4-isopropyl-2-(o-tolyl)oxazoline to aldehydes followed by diastereomer-selective lactonization and obtained 1 with good to high optical activity (Scheme 1).[3]

  • We investigated the reaction of o-toluic acid 4 with benzaldehyde using n-BuLi as base and (-)-sparteine as external chiral ligand at -78 °C (Scheme 2; Equation 1)

Read more

Summary

Introduction

The 3-aryl-3,4-dihydroisocoumarins 1 constitute a class of natural products, which exhibit a wide range of pharmacological activities such as antifungal, antiulcer, antileukemic, antiallergic, differentiation-inducing and antimalarial activities.[1]. Abstract An asymmetric synthesis of 3-aryl-3,4-dihydroisocoumarins using the reaction of laterally lithiated 4,4-dimethyl-2-(o-tolyl)oxazoline with aromatic aldehydes, in the presence of an external chiral ligand, gave products with enantiomeric excess (ee) in the range of 60-70%.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.